// App-Quantinova.ai

: Preoperative trial of neoadjuvant abiraterone plus or minus cabazitaxel: Early results.

Researchers

Presenter

  • Jaime Omar Herrera-Caceres

Principal Investigators

  • Hanan Goldberg

  • Aaron Richard Hansen

  • Srikala S. Sridhar

  • Robert James Hamilton

  • Antonio Finelli

  • Alexandre Zlotta

  • Anthony M. Joshua

  • Neil Eric Fleshner

Medical Centers

  • Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.

  • University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • Princess Margaret Cancer Centre University Health Network, Toronto, Ontario, Canada

  • University of Toronto, Toronto, ON, Canada

  • Department of Surgery, Division of Urology, University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • PEG-filgrastim

  • Cabazitaxel

  • CB-7598

  • Filgrastim

  • LHRH

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved